홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
PTGX
#1033
Protagonist Therapeutics, Inc
92.080
0
+6.88%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+6.88%
월간 변동
+11.68%
6달 변화
+22.56%
년간 변동율
+22.56%
이전 종가
86.150
0
Open
92.210
0
Bid
Ask
Low
92.080
0
High
92.220
0
양
152
마켓
주식
헬스케어
PTGX
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
59.6 M
61.38 M
61.98 M
62.21 M
62.52 M
63.81 M
—
Valuation ratios
Enterprise value
2.55 B
2.27 B
2.86 B
3.27 B
4.04 B
5.44 B
15.61 B
Price to earnings ratio
16.3
9.13
62
75.71
102.2
-42.6
197.31
Price to sales ratio
8.64
5.78
15.04
17.09
20.55
120.66
173.34
Price to cash flow ratio
14.2
13.64
10.56
86.57
62.72
96.28
256.13
Price to book ratio
1.4
3.72
1.25
1.37
1.58
9.03
13.23
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.05
0.01
0.02
0.05
0.06
0.07
0.19
Return on equity %
0.06
0.01
0.02
0.05
0.06
0.07
0.2
Return on invested capital %
152.87
-62.99
33.8
115.72
140.65
169.54
459.71
Gross margin %
100
100
100
100
100
100
400
Operating margin %
886.7
-19.76
68.18
758.04
985.17
677.09
2 488.48
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
710.37
2.36
41.15
626.96
834.87
596.8
2 099.78
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
10.7
12.48
17.26
16.97
13.05
12.71
59.98
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.25
0.04
0.01
0.01
0.01
0.06
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.45
-0.45
1.99
-0.45
-0.03
-0.58
0.93
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
7.59
6.44
9.12
8.98
9.03
8.92
36.06
Net current asset value per share
7.72
9.09
9.62
9.49
9.2
9.09
37.39
Tangible book value per share
8.61
10.38
10.94
10.52
10.12
9.67
41.25
Working capital per share
7
8.36
9.06
8.93
8.49
8.37
34.85
Book value per share
8.61
10.38
10.94
10.52
10.12
9.67
41.25
뉴스
Protagonist Therapeutics Q4 실적, 수익 에상치보다 저조
Protagonist Therapeutics earnings missed by $0.35, revenue fell short of estimates
시티즌스, Protagonist Therapeutics 목표 주가 상향
Citizens raises Protagonist Therapeutics stock price target on drug approvals
Protagonist Therapeutics 임원, 19억 원 상당 주식 매도
Protagonist Therapeutics director Williams sells $1.48 million in shares
프로타고니스트 테라퓨틱스 이사, 167만 달러 상당 주식 매도
Protagonist Therapeutics director sells $1.67 million in shares
2026년 주목할 바이오테크 주요 종목: 트루이스트
Top Biotech Stocks to Watch in 2026, According to Truist
Protagonist Therapeutics 목표 주가, H.C. Wainwright서 117달러로 상향
Protagonist Therapeutics stock price target raised to $117 from $80 at H.C. Wainwright